This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises
guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also …

Pulmonary hypertension (PH), defined by increased pressure within the pulmonary
vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of …

Simple Summary Myxomatous mitral valve disease (MMVD) is the most common acquired
cardiovascular disease in dogs. The progression of the disease and the increasing severity …

Cardiac emergencies include a variety of different diseases, including congestive heart
failure (HF), cardiac tamponade, arrhythmogenic disease, and thromboembolic disease …

В монографии на основе новейших прикладных и фундаментальных достижений
ветеринарной медицины рассматривается наиболее распространенная патология …

Background The prognostic relevance of left atrial (LA) morphological and functional
variables, including those derived from speckle tracking echocardiography (STE), has been …

Background Dogs with degenerative mitral valve disease are commonly presented to small
animal clinicians. Diagnosis, clinical staging, and therapeutic design are based on a …

Acute heart failure in cats represents a complex clinical situation in feline practice and this
review has been designed to focus on the description of acute heart failure in cats, the …

Background Pimobendan and benazepril are frequently used with diuretics to treat dogs in
congestive heart failure (CHF) caused by myxomatous mitral valve disease (MMVD). Aim To …

Background Pimobendan is an important therapy for dogs with myxomatous mitral valve
disease (MMVD). The pharmacokinetics are reported in healthy dogs but not in dogs with …